E-LIB Suche - Ergebnisse für: Di Paolo, Julie A.

1

Characterization of the mechanism of action of lanraplenib,..:

Pohlmeyer, Christopher W. ; Shang, Ching ; Han, Pei...
BMC Rheumatology. 5 (2021) 1 - p. , 2021

2

JAK selectivity and the implications for clinical inhibitio..:

Traves, Paqui G ; Murray, Bernard ; Campigotto, Federico...
Annals of the Rheumatic Diseases. 80 (2021) 7 - p. 865-875 , 2021

Link: https://doi.org/10.1136/..

3

Tu1903 EVALUATION OF POTENTIAL MECHANISMS UNDERLYING THE SA..:

Clarke, Astrid ; Di Paolo, Julie ; Downie, Bryan...
Gastroenterology. 158 (2020) 6 - p. S-1212 , 2020

Link: https://doi.org/10.1016/..

4

Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyr..:

Blomgren, Peter ; Chandrasekhar, Jayaraman ; Di Paolo, Julie A....
ACS Medicinal Chemistry Letters. 11 (2020) 4 - p. 506-513 , 2020

Link: https://doi.org/10.1021/..

5

An inhibitor of spleen tyrosine kinase suppresses experimen..:

Han, Yingjie ; Ma, Frank Y ; Di Paolo, Julie.
International Journal of Immunopathology and Pharmacology. 32 (2018) - p. 205873841878340 , 2018

Link: https://doi.org/10.1177/..

6

Regulation and function of apoptosis signal-regulating kina..:

Nygaard, Gyrid ; Di Paolo, Julie A. ; Hammaker, Deepa...
Biochemical Pharmacology. 151 (2018) - p. 282-290 , 2018

Link: https://doi.org/10.1016/..

7

Effects of GS-9876, a novel spleen tyrosine kinase inhibito..:

Clarke, Astrid S. ; Rousseau, Emma ; Wang, Kelly...
Thrombosis Research. 170 (2018) - p. 109-118 , 2018

Link: https://doi.org/10.1016/..

8

Discovery of highly potent and selective Bruton's tyrosine ..:

Young, Wendy B. ; Barbosa, James ; Blomgren, Peter...
Bioorganic & Medicinal Chemistry Letters. 26 (2016) 2 - p. 575-579 , 2016

Link: https://doi.org/10.1016/..

9

Targeting B-cell receptor signaling kinases in chronic lymp..:

Sharman, Jeff ; Di Paolo, Julie
Therapeutic Advances in Hematology. 7 (2016) 3 - p. 157-170 , 2016

Link: https://doi.org/10.1177/..

10

Pharmacokinetics, Pharmacodynamics, and Safety of Entosplet..:

Ramanathan, Srini ; Di Paolo, Julie A. ; Jin, Feng...
Clinical Drug Investigation. 37 (2016) 2 - p. 195-205 , 2016

Link: https://doi.org/10.1007/..

11

Potent and selective Bruton's tyrosine kinase inhibitors: D..:

Young, Wendy B. ; Barbosa, James ; Blomgren, Peter...
Bioorganic & Medicinal Chemistry Letters. 25 (2015) 6 - p. 1333-1337 , 2015

Link: https://doi.org/10.1016/..

12

Discovery of GS-9973, a Selective and Orally Efficacious In..:

Currie, Kevin S. ; Kropf, Jeffrey E. ; Lee, Tony...
Journal of Medicinal Chemistry. 57 (2014) 9 - p. 3856-3873 , 2014

Link: https://doi.org/10.1021/..

13

Characterization of the mechanism of action of lanraplenib,..:

Pohlmeyer, Christopher W ; Shang, Ching ; Han, Pei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008554/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyr..:

Blomgren, Peter ; Chandrasekhar, Jayaraman ; Di Paolo, Julie A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153012/. , 2020

Link: http://www.ncbi.nlm.nih...

15

An inhibitor of spleen tyrosine kinase suppresses experimen..:

Han, Yingjie ; Ma, Frank Y ; Di Paolo, Julie.
Han , Y , Ma , F Y , Di Paolo , J & Nikolic-Paterson , D J 2018 , ' An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis ' , International Journal of Immunopathology and Pharmacology , vol. 32 . https://doi.org/10.1177/2058738418783404. , 2018

Link: https://research.monash...